These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8497615)

  • 1. Early-enhancing pseudolesion in medial segment of left hepatic lobe detected with multisection dynamic MR.
    Ito K; Choji T; Fujita T; Matsumoto T; Nakada T; Nakanishi T
    Radiology; 1993 Jun; 187(3):695-9. PubMed ID: 8497615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic pseudolesion: appearance of focal low attenuation in the medial segment of the left lobe at CT arterial portography.
    del Pilar Fernandez M; Bernardino ME
    Radiology; 1991 Dec; 181(3):809-12. PubMed ID: 1947102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced MR imaging of the liver after ethanol treatment of hepatocellular carcinoma: evaluation of areas of hyperperfusion adjacent to the tumor.
    Ito K; Honjo K; Fujita T; Awaya H; Matsumoto T; Matsunaga N
    AJR Am J Roentgenol; 1995 Jun; 164(6):1413-7. PubMed ID: 7754884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis or chronic hepatitis: evaluation of small (Shimizu A; Ito K; Koike S; Fujita T; Shimizu K; Matsunaga N
    Radiology; 2003 Feb; 226(2):550-5. PubMed ID: 12563153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontumorous hepatic pseudolesion around the falciform ligament: prevalence on gadolinium chelate-enhanced MR examination.
    Spelle L; Soyer P; Rondeau Y; Gouhiri M; Scherrer A; Rymer R
    AJR Am J Roentgenol; 1997 Sep; 169(3):795-9. PubMed ID: 9275899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic contrast-enhanced multisection dynamic MR imaging of the liver: potential pitfalls.
    Ito K; Mitchell DG; Honjo K; Fujita T; Awaya H; Matsumoto T; Matsunaga N
    Radiographics; 1997; 17(3):693-705. PubMed ID: 9153706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolesions of left liver lobe during helical CT examinations: prevalence and comparison between unenhanced and biphasic CT findings.
    Koseoglu K; Ozsunar Y; Taskin F; Karaman C
    Eur J Radiol; 2005 Jun; 54(3):388-92. PubMed ID: 15899341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic pseudolesion around the falciform ligament: prevalence, aberrant venous supply, and fatty infiltration evaluated by multidetector computed tomography and magnetic resonance imaging.
    Genchellac H; Yilmaz S; Ucar A; Dursun M; Demir MK; Yekeler E
    J Comput Assist Tomogr; 2007; 31(4):526-33. PubMed ID: 17882026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
    Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
    Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions.
    Ito K; Fujita T; Shimizu A; Koike S; Sasaki K; Matsunaga N; Hibino S; Yuhara M
    AJR Am J Roentgenol; 2004 Sep; 183(3):699-705. PubMed ID: 15333358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
    Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
    Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular adenoma: MR imaging features with pathologic correlation.
    Chung KY; Mayo-Smith WW; Saini S; Rahmouni A; Golli M; Mathieu D
    AJR Am J Roentgenol; 1995 Aug; 165(2):303-8. PubMed ID: 7618545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.